https://realnewsmagazine.net/final-results-from-the-procid-study-of-efficacy-and-safety-of-3-different-dosages-of-panzyga-newgam-in-patients-with-chronic-inflammatory-demyelinating-polyneuropathy-cidp-presented-at-aan-2020/
Final results from the ProCID study of efficacy and safety of 3 different dosages of Panzyga (NewGam) in patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) presented at AAN 2020